Introduction:
Integrating innovations across xenotransplantation, regenerative medicine, and bioartificial organs is critical to addressing the global organ shortage. A PubMed search on “bioartificial organs” yields 1,343 results, reflecting the substantial contributions from these fields since the first Vacanti cell transplantation article in 1988. These sectors, once siloed, are now converging through technological advancements, particularly in artificial intelligence (AI), which could eliminate the organ shortage within the next 10-15 years.
Methods:
Journal editors have historically played a crucial role in fostering this convergence. In the past, direct communication between these sectors was limited. However, editors have facilitated interdisciplinary dialogue and collaboration through curated special issues, such as the September 2022 issue of Cells Tissues Organs, which focused on bioartificial organs. This has significantly accelerated innovation across the fields.
As we look to the future, AI will increasingly complement the role of journal editors. AI’s ability to analyze vast datasets, identify interdisciplinary connections, and predict emerging trends will drive further innovation and collaboration. Moreover, AI can enhance the efficiency of information management and dissemination, surpassing traditional methods in speed and reach.
Results:
Given the rapid pace of medical advancements, traditional journal publications may soon be inadequate. Video content and other digital media will become pivotal in documenting and sharing progress in real-time, providing a more immediate and accessible platform for researchers globally.
China’s growing contributions to xenotransplantation, regenerative medicine, and bioartificial organs underscore the global nature of this endeavour. Integrating AI and innovative communication strategies will be essential to maintaining a collaborative and competitive edge.
The new American Society of Transplantation (AST) Transplant Regenerative Medicine Advisory Council brings expertise in xenotransplantation and regenerative medicine. For completeness, it lacks only bioartificial organs. One can imagine future ISN-AST joint collaborations in organ transplantation.
Conclusions:
Journal editors and AI are key drivers in bridging the gaps between xenotransplantation, regenerative medicine, and bioartificial organs and finding common elements to support. Their collaborative efforts will be crucial in ending the organ shortage in the next 10-15 years. Significant advancements in transplantation science can be achieved by facilitating communication, fostering innovation, and transitioning to more dynamic methods of information dissemination. This integrated approach will ensure progress remains dynamic, inclusive, and aligned with the rapid pace of medical and technological advancements.
I have no potential conflict of interest to disclose.
I did not use generative AI and AI-assisted technologies in the writing process.